Trades on 1 secondary market

Dewpoint

Dewpoint Therapeutics is a Boston-based biotechnology company, founded in 2018, that pioneers drug discovery based on biomolecular condensates — the membraneless compartments inside cells whose formation and dysregulation underlie many diseases. Its condensate platform combines cell biology, high-th

minimal 5.7 / 100 0 APIs View provider profile →

Company Health Tech Biotech Drug Discovery Pharmaceuticals Life Sciences

Dewpoint is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.